We recommend the possible routine use of cardiac MRI for early diagnosis of cardiac involvement in CLN3 disease (also termed juvenile NCL) and to monitor the effects of emerging CLN3 therapies on the myocardium as well. This evidence concerns the gene CLN3 and neuronal ceroid lipofuscinosis.